Peter Lauer

Energy Biosciences Institute — United States

Immunology and Microbiology · Life Sciences

40h-index12.7kcitations128works2.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Immunotherapy and Immune Responses(31), Cancer Immunotherapy and Biomarkers(17), Cancer Research and Treatments(13), Listeria monocytogenes in Food Safety(11), CAR-T cell therapy research(11)

Publications127 total

Abstract 6323: Preclinical evaluation of CB-012, an allogeneic anti-CLL-1 CAR-T cell therapy, that exhibits specific and potent toxicity in acute myeloid leukemia (AML) xenograft models
Cancer Research·2024· 2 cited
CLL-1-Targeted Allogeneic CAR-T Cells Exhibit High on-Target Specificity and Potent Cytotoxicity in Preclinical Models of Acute Myeloid Leukemia
Blood·2023· 4 citedOpen Access
Supplemental Figure 3 from Systemic Tolerance Mediated by Melanoma Brain Tumors Is Reversible by Radiotherapy and Vaccination
2023Open Access
Supplemental Figure 1 from Systemic Tolerance Mediated by Melanoma Brain Tumors Is Reversible by Radiotherapy and Vaccination
2023Open Access
Data from Systemic Tolerance Mediated by Melanoma Brain Tumors Is Reversible by Radiotherapy and Vaccination
2023Open Access
Supplemental Figure 3 from Systemic Tolerance Mediated by Melanoma Brain Tumors Is Reversible by Radiotherapy and Vaccination
2023Open Access
Supplemental Figure 6 from Systemic Tolerance Mediated by Melanoma Brain Tumors Is Reversible by Radiotherapy and Vaccination
2023Open Access
Supplemental Figure 5 from Systemic Tolerance Mediated by Melanoma Brain Tumors Is Reversible by Radiotherapy and Vaccination
2023Open Access
Supplemental Figure 6 from Systemic Tolerance Mediated by Melanoma Brain Tumors Is Reversible by Radiotherapy and Vaccination
2023Open Access
Supplemental Figure 4 from Systemic Tolerance Mediated by Melanoma Brain Tumors Is Reversible by Radiotherapy and Vaccination
2023Open Access
Supplemental Figure 1 from Systemic Tolerance Mediated by Melanoma Brain Tumors Is Reversible by Radiotherapy and Vaccination
2023Open Access
Supplemental Figure 2 from Systemic Tolerance Mediated by Melanoma Brain Tumors Is Reversible by Radiotherapy and Vaccination
2023Open Access
Supplemental Figure 2 from Systemic Tolerance Mediated by Melanoma Brain Tumors Is Reversible by Radiotherapy and Vaccination
2023Open Access
Data from Systemic Tolerance Mediated by Melanoma Brain Tumors Is Reversible by Radiotherapy and Vaccination
2023Open Access
Supplemental Figure 4 from Systemic Tolerance Mediated by Melanoma Brain Tumors Is Reversible by Radiotherapy and Vaccination
2023Open Access
Supplemental Figure 5 from Systemic Tolerance Mediated by Melanoma Brain Tumors Is Reversible by Radiotherapy and Vaccination
2023Open Access
STING controls T cell memory fitness during infection through T cell-intrinsic and IDO-dependent mechanisms
Proceedings of the National Academy of Sciences·2023· 23 citedOpen Access
STING controls T cell memory fitness during infection through T cell intrinsic and IDO dependent mechanisms
2022· 2 citedOpen Access
An autoimmune stem-like CD8 T cell population drives type 1 diabetes
Nature·2021· 232 citedOpen Access
Safety and preliminary immunogenicity of JNJ-64041809, a live-attenuated, double-deleted Listeria monocytogenes-based immunotherapy, in metastatic castration-resistant prostate cancer
Prostate Cancer and Prostatic Diseases·2021· 31 citedOpen Access
page 1 of 7Next →

Frequent Co-authors

Dirk G. Brockstedt(12), Thomas W. Dubensky(10), Daniel A. Portnoy(9), Andrea Schietinger(4), Meredith L. Leong(4), Edward E. Lemmens(4), Bill Hanson(4), Andreas Petzold(4), Mojdeh Shakiba(3), Mary Philip(3), Weiqun Liu(3), Drew M. Pardoll(3), Michael Koomey(3), Marco Soriani(3), Roberto Rosini(3), Guido Grandi(3), John L. Telford(3), J. Hasselbach(3), Keith S. Bahjat(3), Justin Skoble(3)